1
|
Goldstein A, Lanhers C, Gay C, Dubourg K, Grange L, Roques CF, Pereira B, Coudeyre E. Efficacy of self-management program associated with a spa therapy for knee osteoarthritis patients (GETT 2): a research protocol for a randomized trial. Trials 2023; 24:45. [PMID: 36658607 PMCID: PMC9854168 DOI: 10.1186/s13063-022-06879-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2022] [Accepted: 11/01/2022] [Indexed: 01/21/2023] Open
Abstract
INTRODUCTION Osteoarthritis is a chronic pathology that involves multidisciplinary management. Self-management for patients is an essential element, present in all international guidelines. During the time of the spa therapy, the patient is receptive to take the advantage of self-management workshops. The aim of this study is to assess the effects of 18 days spa therapy associated with a self-management intervention in patients with knee osteoarthritis in comparison with spa therapy alone on a priority objective, personalized and determined with the patient, chosen in the list of 5 objectives determined during the self-management initial assessment. METHODS AND ANALYSIS Two hundred fifty participants with knee osteoarthritis will participate to this multicenter, prospective, randomized, controlled study. All patients will benefit 18 days of spa therapy and patients randomized in the intervention group will participate to 6 self-management workshops. Randomization will be centralized. The allocation ratio will be 1:1. Data analysts and assessor will be blinded. The primary outcome is the effectiveness of the educational workshops associated with spa therapy in comparison with spa therapy alone on a priority objective, measured by Goal Attainment Scaling (GAS). The secondary outcomes are disability, health-related quality of life, and pain intensity. ETHICS AND DISSEMINATION Ethics were approved by the CPP Sud-Méditerranée II. The results will be disseminated in a peer-reviewed journal and disseminated at PRM, rheumatology, and orthopedics conferences. The results will also be disseminated to patients. TRIAL REGISTRATION Trial registration number NCT03550547. Registered 8 June 2018. Date and version identifier of the protocol. Version N°6 of March 12, 2018.
Collapse
Affiliation(s)
- A. Goldstein
- grid.494717.80000000115480420Service de Médecine Physique et de Réadaptation, CHU Clermont-Ferrand, Université Clermont Auvergne, INRAE, UNH, F-63000 Clermont–Ferrand, France
| | - C. Lanhers
- grid.494717.80000000115480420Service de Médecine Physique et de Réadaptation, CHU Clermont-Ferrand, Université Clermont Auvergne, INRAE, UNH, F-63000 Clermont–Ferrand, France
| | - C. Gay
- grid.494717.80000000115480420Service de Santé Publique, CHU de Clermont Ferrand, PEPRADE, Université Clermont Auvergne, Clermont–Ferrand, France
| | - K. Dubourg
- grid.412041.20000 0001 2106 639XUniversité de Bordeaux, Institut du Thermalisme, Dax, France
| | - L. Grange
- Service de Rhumatologie, C.H.U.G.A Hôpital Sud, Échirolles, France
| | | | - B. Pereira
- grid.494717.80000000115480420Délégation Recherche Clinique et Innovation, CHU de Clermont Ferrand, Université Clermont Auvergne, Clermont–Ferrand, France
| | - E. Coudeyre
- grid.494717.80000000115480420Service de Médecine Physique et de Réadaptation, CHU Clermont-Ferrand, Université Clermont Auvergne, INRAE, UNH, F-63000 Clermont–Ferrand, France
| |
Collapse
|
2
|
Raptis CA, Goldstein A, Henry TS, Porter KK, Catenacci D, Kelly AM, Kuzniewski CT, Lai AR, Lee E, Long JM, Martin MD, Morris MF, Sandler KL, Sirajuddin A, Surasi DS, Wallace GW, Kamel IR, Donnelly EF. ACR Appropriateness Criteria® Staging and Follow-Up of Esophageal Cancer. J Am Coll Radiol 2022; 19:S462-S472. [PMID: 36436970 DOI: 10.1016/j.jacr.2022.09.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2022] [Accepted: 09/01/2022] [Indexed: 11/27/2022]
Abstract
This document provides recommendations regarding the role of imaging in the staging and follow-up of esophageal cancer. For initial clinical staging, locoregional extent and nodal disease are typically assessed with esophagogastroduodenoscopy and esophageal ultrasound. FDG-PET/CT or CT of the chest and abdomen is usually appropriate for use in initial clinical staging as they provide additional information regarding distant nodal and metastatic disease. The detection of metastatic disease is critical in the initial evaluation of patients with esophageal cancer because it will direct patients to a treatment pathway centered on palliative radiation rather than surgery. For imaging during treatment, particularly neoadjuvant chemotherapy, FDG-PET/CT is usually appropriate, because some studies have found that it can provide information regarding primary lesion response, but more importantly it can be used to detect metastases that have developed since the induction of treatment. For patients who have completed treatment, FDG-PET/CT or CT of the chest and abdomen is usually appropriate for evaluating the presence and extent of metastases in patients with no suspected or known recurrence and in those with a suspected or known recurrence. The ACR Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.
Collapse
Affiliation(s)
| | - Alan Goldstein
- Division Chief, Abdominal Imaging, Director of CT Colonography, UMass Medical School, Worcester, Massachusetts
| | - Travis S Henry
- Panel Chair; Division Chief of Cardiothoracic Imaging, Duke University, Durham, North Carolina; Co-Director, ACR Education Center HRCT Course
| | - Kristin K Porter
- Panel Chair, University of Alabama Medical Center, Birmingham, Alabama; ACR Council Steering Committee
| | - Daniel Catenacci
- The University of Chicago, Chicago, Illinois; American Society of Clinical Oncology
| | - Aine Marie Kelly
- Assistant Program Director Radiology Residency, Emory University Hospital, Atlanta, Georgia
| | | | - Andrew R Lai
- Hospitalist; University of California San Francisco (UCSF), San Francisco, California; Former Director of the UCSF Hospitalist Procedure Service; Former Director of the UCSF Division of Hospital Medicine's Case Review Committee; Former Director of Procedures/Quality Improvement Rotation for the UCSF Internal Medicine Residency
| | - Elizabeth Lee
- Director, M1 Radiology Education, University of Michigan Medical School; Associate Program Director, Diagnostic Radiology, Michigan Medicine; Director of Residency Education Cardiothoracic Division, Michigan Medicine, University of Michigan Health System, Ann Arbor, Michigan
| | - Jason M Long
- Director of Robotic Thoracic Surgery, Director of Lung Cancer Screening, University of North Carolina Hospital, Chapel Hill, North Carolina; The Society of Thoracic Surgeons
| | - Maria D Martin
- Director, Diversity and Inclusion, Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
| | - Michael F Morris
- Director of Cardiac CT and MRI, University of Arizona College of Medicine, Phoenix, Arizona
| | - Kim L Sandler
- Co-Director Vanderbilt Lung Screening Program, Vanderbilt University Medical Center, Nashville, Tennessee; Imaging Chair, Thoracic Committee, ECOG-ACRIN; Co-Chair, Lung Screening 2.0 Steering Committee
| | | | - Devaki Shilpa Surasi
- Patient Safety and Quality Officer, Department of Nuclear Medicine, Chair-Elect, Junior Faculty Committee, The University of Texas MD Anderson Cancer Center, Houston, Texas; Commission on Nuclear Medicine and Molecular Imaging
| | | | - Ihab R Kamel
- Specialty Chair, Johns Hopkins University School of Medicine, Baltimore, Maryland
| | - Edwin F Donnelly
- Specialty Chair; Chief of Thoracic Radiology, Interim Vice Chair of Academic Affairs, Department of Radiology, Ohio State University Wexner Medical Center, Columbus, Ohio
| |
Collapse
|
3
|
Krapf J, Mautz T, Lorenzini S, Holloway J, Goldstein A. Clinical Presentation of Clitorodynia associated with Clitoral Adhesions and Keratin Pearls. J Sex Med 2022. [DOI: 10.1016/j.jsxm.2022.05.032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
|
4
|
Goldstein I, Yee A, Uloko M, Goldstein A. Extent of surgical excision of the vestibule based on positive CD117 and PGP9.5 staining of mast cells in women with neuroproliferative vestibulodynia. J Sex Med 2022. [DOI: 10.1016/j.jsxm.2022.03.394] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
5
|
Vij A, Zaheer A, Kamel IR, Porter KK, Arif-Tiwari H, Bashir MR, Fung A, Goldstein A, Herr KD, Kamaya A, Kobi M, Landler MP, Russo GK, Thakrar KH, Turturro MA, Wahab SA, Wardrop RM, Wright CL, Yang X, Carucci LR. ACR Appropriateness Criteria® Epigastric Pain. J Am Coll Radiol 2021; 18:S330-S339. [PMID: 34794592 DOI: 10.1016/j.jacr.2021.08.006] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2021] [Accepted: 08/26/2021] [Indexed: 12/23/2022]
Abstract
Epigastric pain can have multiple etiologies including myocardial infarction, pancreatitis, acute aortic syndromes, gastroesophageal reflux disease, esophagitis, peptic ulcer disease, gastritis, duodenal ulcer disease, gastric cancer, and hiatal hernia. This document focuses on the scenarios in which epigastric pain is accompanied by symptoms such as heartburn, regurgitation, dysphagia, nausea, vomiting, and hematemesis, which raise suspicion for gastroesophageal reflux disease, esophagitis, peptic ulcer disease, gastritis, duodenal ulcer disease, gastric cancer, or hiatal hernia. Although endoscopy may be the test of choice for diagnosing these entities, patients may present with nonspecific or overlapping symptoms, necessitating the use of imaging prior to or instead of endoscopy. The utility of fluoroscopic imaging, CT, MRI, and FDG-PET for these indications are discussed. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
Collapse
Affiliation(s)
- Abhinav Vij
- New York University Langone Medical Center, New York, New York; and UT Southwestern Medical Center, Dallas, Texas.
| | - Atif Zaheer
- Johns Hopkins Hospital, Baltimore, Maryland; Chair, Disease Focus Panel for Pancreatitis, Society of Abdominal Radiology; and Associate Editor, Journal Abdominal Radiology
| | - Ihab R Kamel
- Panel Chair, Johns Hopkins University School of Medicine, Baltimore, Maryland
| | - Kristin K Porter
- Panel Vice-Chair, University of Alabama Medical Center, Birmingham, Alabama; and Board of Directors/President (2021), American Association for Women in Radiology
| | - Hina Arif-Tiwari
- University of Arizona, Banner University Medical Center, Tucson, Arizona
| | - Mustafa R Bashir
- Associate Vice-Chair for Research, Department of Radiology, Duke University Medical Center, Durham, North Carolina
| | - Alice Fung
- Oregon Health & Science University, Portland, Oregon
| | - Alan Goldstein
- Division Chief, Abdominal Imaging, University of Massachusetts Medical School, Worcester, Massachusetts
| | | | - Aya Kamaya
- Stanford University Medical Center, Stanford, California; and President-Elect (2020-2021) and President (2021-2022), Society of Radiologists in Ultrasound
| | | | - Matthew P Landler
- Northwestern University Feinberg School of Medicine, Chicago, Illinois; Primary care physician
| | | | | | - Michael A Turturro
- University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; American College of Emergency Physicians
| | - Shaun A Wahab
- University of Cincinnati Medical Center, Cincinnati, Ohio
| | - Richard M Wardrop
- The University of Mississippi Medical Center, Jackson, Mississippi; American College of Physicians; Member, American Board of Internal Medicine; Internal Medicine Specialty Board; and Program Director, Cleveland Clinic
| | - Chadwick L Wright
- The Ohio State University Wexner Medical Center, Columbus, Ohio; Board of Directors, American Board of Science in Nuclear Medicine (ABSNM); and Board of Directors, American College of Nuclear Medicine (ACNM)
| | - Xihua Yang
- Phoenix Indian Medical Center, Phoenix, Arizona; American College of Surgeons; and Volunteer Board Member, Franklin Pierce PA School
| | - Laura R Carucci
- Specialty Chair; and Director, CT and MRI, and Section Chief, Abdominal Imaging, Virginia Commonwealth University Medical Center, Richmond, Virginia
| |
Collapse
|
6
|
Alves CAPF, Goldstein A, Teixeira SR, Martin-Saavedra JS, de Barcelos IP, Fadda G, Caschera L, Kidd M, Gonçalves FG, McCormick EM, Falk MJ, Zolkipli-Cunningham Z, Vossough A, Zuccoli G. Involvement of the Spinal Cord in Primary Mitochondrial Disorders: A Neuroimaging Mimicker of Inflammation and Ischemia in Children. AJNR Am J Neuroradiol 2021; 42:389-396. [PMID: 33384291 PMCID: PMC7872189 DOI: 10.3174/ajnr.a6910] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2020] [Accepted: 09/25/2020] [Indexed: 01/04/2023]
Abstract
BACKGROUND AND PURPOSE Little is known about imaging features of spinal cord lesions in mitochondrial disorders. The aim of this research was to assess the frequency, imaging features, and pathogenic variants causing primary mitochondrial disease in children with spinal cord lesions. MATERIALS AND METHODS This retrospective analysis included patients seen at Children's Hospital of Philadelphia between 2000 and 2019 who had a confirmed diagnosis of a primary (genetic-based) mitochondrial disease and available MR imaging of the spine. The MR imaging included at least both sagittal and axial fast spin-echo T2-weighted images. Spine images were independently reviewed by 2 neuroradiologists. Location and imaging features of spinal cord lesions were correlated and tested using the Fisher exact test. RESULTS Of 119 children with primary mitochondrial disease in whom MR imaging was available, only 33 of 119 (28%) had available spine imaging for reanalysis. Nineteen of these 33 individuals (58%) had evidence of spinal cord lesions. Two main patterns of spinal cord lesions were identified: group A (12/19; 63%) had white ± gray matter involvement, and group B (7/19; 37%) had isolated gray matter involvement. Group A spinal cord lesions were similar to those seen in patients with neuromyelitis optica spectrum disorder, multiple sclerosis, anti-myelin oligodendrocyte glycoprotein-IgG antibody disease, and leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Group B patients had spinal cord findings similar to those that occur with ischemia and viral infections. Significant associations were seen between the pattern of lesions (group A versus group B) and the location of lesions in cervical versus thoracolumbar segments, respectively (P < .01). CONCLUSIONS Spinal cord lesions are frequently observed in children with primary mitochondrial disease and may mimic more common causes such as demyelination and ischemia.
Collapse
Affiliation(s)
- C A P F Alves
- From the Division of Neuroradiology, Department of Radiology (C.A.P.F.A., S.R.T., J.S.M.S., L.C., F.G.G., A.V., G.Z.)
| | - A Goldstein
- Division of Human Genetics, Department of Pediatrics (A.G., E.M.M., M.J.F., Z.Z.-C.), Mitochondrial Medicine Frontier Program
- Pediatrics (A.G., M.J.F., Z.Z.-C.) University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
| | - S R Teixeira
- From the Division of Neuroradiology, Department of Radiology (C.A.P.F.A., S.R.T., J.S.M.S., L.C., F.G.G., A.V., G.Z.)
| | - J S Martin-Saavedra
- From the Division of Neuroradiology, Department of Radiology (C.A.P.F.A., S.R.T., J.S.M.S., L.C., F.G.G., A.V., G.Z.)
| | - I P de Barcelos
- Division of Human Genetics (I. P.d.B.), Department of Pediatrics, Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
| | - G Fadda
- Departments of Neurology (G.F.)
| | - L Caschera
- From the Division of Neuroradiology, Department of Radiology (C.A.P.F.A., S.R.T., J.S.M.S., L.C., F.G.G., A.V., G.Z.)
- Neuroradiology Unit (L.C.), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, Milan, Italy
| | - M Kidd
- Centre for Statistical Consultation (M.K.), University of Stellenbosch, South Africa
| | - F G Gonçalves
- From the Division of Neuroradiology, Department of Radiology (C.A.P.F.A., S.R.T., J.S.M.S., L.C., F.G.G., A.V., G.Z.)
| | - E M McCormick
- Division of Human Genetics, Department of Pediatrics (A.G., E.M.M., M.J.F., Z.Z.-C.), Mitochondrial Medicine Frontier Program
| | - M J Falk
- Division of Human Genetics, Department of Pediatrics (A.G., E.M.M., M.J.F., Z.Z.-C.), Mitochondrial Medicine Frontier Program
- Pediatrics (A.G., M.J.F., Z.Z.-C.) University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
| | - Z Zolkipli-Cunningham
- Division of Human Genetics, Department of Pediatrics (A.G., E.M.M., M.J.F., Z.Z.-C.), Mitochondrial Medicine Frontier Program
- Pediatrics (A.G., M.J.F., Z.Z.-C.) University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
| | - A Vossough
- From the Division of Neuroradiology, Department of Radiology (C.A.P.F.A., S.R.T., J.S.M.S., L.C., F.G.G., A.V., G.Z.)
| | - G Zuccoli
- From the Division of Neuroradiology, Department of Radiology (C.A.P.F.A., S.R.T., J.S.M.S., L.C., F.G.G., A.V., G.Z.)
- The Program for the Study of Neurodevelopment in Rare Disorders (G.Z.), Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania
| |
Collapse
|
7
|
Chernyak V, Horowitz JM, Kamel IR, Arif-Tiwari H, Bashir MR, Cash BD, Farrell J, Goldstein A, Grajo JR, Gupta S, Hindman NM, Kamaya A, McNamara MM, Porter KK, Solnes LB, Srivastava PK, Zaheer A, Carucci LR. ACR Appropriateness Criteria® Liver Lesion-Initial Characterization. J Am Coll Radiol 2020; 17:S429-S446. [PMID: 33153555 DOI: 10.1016/j.jacr.2020.09.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2020] [Accepted: 09/01/2020] [Indexed: 02/08/2023]
Abstract
Incidental liver masses are commonly identified on imaging performed for other indications. Since the prevalence of benign focal liver lesions in adults is high, even in patients with primary malignancy, accurate characterization of incidentally detected lesions is of paramount clinical importance. This document reviews utilization of various imaging modalities for characterization of incidentally detected liver lesions, discussed in the context of several clinical scenarios. For each clinical scenario, a summary of current evidence supporting the use of a given diagnostic modality is reported. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
Collapse
Affiliation(s)
| | | | - Ihab R Kamel
- Panel Chair, Johns Hopkins University School of Medicine, Baltimore, Maryland
| | - Hina Arif-Tiwari
- University of Arizona, Banner University Medical Center, Tucson, Arizona
| | | | - Brooks D Cash
- University of Texas Health Science Center at Houston and McGovern Medical School, Houston, Texas; American Gastroenterological Association
| | - James Farrell
- Interventional Endoscopy and Pancreatic Diseases, New Haven, Connecticut; American Gastroenterological Association
| | | | - Joseph R Grajo
- University of Florida College of Medicine, Gainesville, Florida
| | - Samir Gupta
- Rush University Medical Center, Chicago, Illinois; American College of Surgeons
| | | | - Aya Kamaya
- Stanford University Medical Center, Stanford, California
| | | | | | | | - Pavan K Srivastava
- University of Illinois College of Medicine, Chicago, Illinois; American College of Physicians
| | | | - Laura R Carucci
- Specialty Chair, Virginia Commonwealth University Medical Center, Richmond, Virginia
| |
Collapse
|
8
|
Hindman NM, Arif-Tiwari H, Kamel IR, Al-Refaie WB, Bartel TB, Cash BD, Chernyak V, Goldstein A, Grajo JR, Horowitz JM, Kamaya A, McNamara MM, Porter KK, Srivastava PK, Zaheer A, Carucci LR. ACR Appropriateness Criteria ® Jaundice. J Am Coll Radiol 2020; 16:S126-S140. [PMID: 31054739 DOI: 10.1016/j.jacr.2019.02.012] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2019] [Accepted: 02/08/2019] [Indexed: 02/07/2023]
Abstract
Jaundice is the end result of myriad causes, which makes the role of imaging in this setting particularly challenging. In the United States, the most common causes of all types of jaundice fall into four categories including hepatitis, alcoholic liver disease, blockage of the common bile duct by a gallstone or tumor, and toxic reaction to a drug or medicinal herb. Clinically, differentiating between the various potential etiologies of jaundice requires a detailed history, targeted physical examination, and pertinent laboratory studies, the results of which allow the physician to categorize the type of jaundice into mechanical or nonmechanical causes. Imaging modalities used to evaluate the jaundiced patient (all etiologies) include abdominal ultrasound (US), CT, MR cholangiopancreatography, endoscopic retrograde cholangiopancreatography and endoscopic US. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
Collapse
Affiliation(s)
| | | | - Hina Arif-Tiwari
- University of Arizona, Banner University Medical Center, Tucson, Arizona
| | - Ihab R Kamel
- Panel Chair, Johns Hopkins University School of Medicine, Baltimore, Maryland
| | - Waddah B Al-Refaie
- Georgetown University Hospital, Washington, District of Columbia; American College of Surgeons
| | | | - Brooks D Cash
- University of Texas McGovern Medical School, Houston, Texas; American Gastroenterological Association
| | | | | | - Joseph R Grajo
- University of Florida College of Medicine, Gainesville, Florida
| | | | - Aya Kamaya
- Stanford University Medical Center, Stanford, California
| | | | | | - Pavan K Srivastava
- University of Illinois College of Medicine, Chicago, Illinois; American College of Physicians
| | | | - Laura R Carucci
- Specialty Chair, Virginia Commonwealth University Medical Center, Richmond, Virginia
| |
Collapse
|
9
|
Shirakov A, Burshtein Z, Goldstein A, Frumker E, Ishaaya AA. Use of Co 2+:MgAl 2O 4 transparent ceramics in passive Q-switching of an Er:Glass laser at 1.534 µm. Opt Express 2020; 28:21956-21970. [PMID: 32752466 DOI: 10.1364/oe.398246] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/20/2020] [Accepted: 06/22/2020] [Indexed: 06/11/2023]
Abstract
We present the implementation of Co2+:MgAl2O4 transparent ceramics as passive Q-switching elements in an Er:Glass laser at 1.534 µm. Linearly polarized pulsed output was obtained by Brewster angle inclination of the material Q-switching plate relative to the laser axis. Separate pulses were ∼105 ns long (FWHM), exhibiting ∼6.2 kW peak power at near TEM00 quality. Several fundamental sample properties important for laser intracavity operation were measured; thermo-optic coefficient dn/dT = ( - 3.8 ± 1) × 10-5 °C-1, thermal lensing factor L-1d(nL)/dT = 2.59 × 10-5 °C-1, linear expansion coefficient α = (3.9 ± 0.6) × 10-5 °C-1, polarizability thermal coefficient ϕ = (7.2 ± 2.2) × 10-5 °C-1, and damage threshold ∼6.5 J/cm2.
Collapse
|
10
|
Goldstein A, Mitchell L, Tolson H, Krapf J. 027 Plasma Cell Mucositis of the Vagina and Cervix. J Sex Med 2020. [DOI: 10.1016/j.jsxm.2020.04.263] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
11
|
Gonçalves FG, Hill B, Guo Y, Muraresku CC, McCormick E, Alves CAPF, Teixeira SR, Martin-Saavedra JS, Zolkipli-Cunningham Z, Falk MJ, Vossough A, Goldstein A, Zuccoli G. The Perirolandic Sign: A Unique Imaging Finding Observed in Association with Polymerase γ-Related Disorders. AJNR Am J Neuroradiol 2020; 41:917-922. [PMID: 32381541 DOI: 10.3174/ajnr.a6514] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2019] [Accepted: 02/27/2020] [Indexed: 11/07/2022]
Abstract
Pathogenic variants in the polymerase γ gene (POLG) cause a diverse group of pathologies known as POLG-related disorders. In this report, we describe brain MR imaging findings and electroencephalogram correlates of 13 children with POLG-related disorders at diagnosis and follow-up. At diagnosis, all patients had seizures and 12 had abnormal MR imaging findings. The most common imaging findings were unilateral or bilateral perirolandic (54%) and unilateral or bilateral thalamic signal changes (77%). Association of epilepsia partialis continua with perirolandic and thalamic signal changes was present in 86% and 70% of the patients, respectively. The occipital lobe was affected in 2 patients. On follow-up, 92% of the patients had disease progression or fatal outcome. Rapid volume loss was seen in 77% of the patients. The occipital lobe (61%) and thalamus (61%) were the most affected brain regions. Perirolandic signal changes and seizures may represent a brain imaging biomarker of early-onset pediatric POLG-related disorders.
Collapse
Affiliation(s)
- F G Gonçalves
- From the Departments of Radiology and Division of Neuroradiology (F.G.G., B.H., C.A.P.F.A., S.R.T., J.S.M.-S., A.V., G.Z.)
| | - B Hill
- From the Departments of Radiology and Division of Neuroradiology (F.G.G., B.H., C.A.P.F.A., S.R.T., J.S.M.-S., A.V., G.Z.)
| | - Y Guo
- Departments of Pediatrics (Y.G., Z.Z.-C., M.J.F., A.G.)
| | - C C Muraresku
- Mitochondrial Medicine Frontier Program, Division of Human Genetics (C.C.M., E.M., Z.Z.-C., M.J.F., A.G.), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
| | - E McCormick
- Mitochondrial Medicine Frontier Program, Division of Human Genetics (C.C.M., E.M., Z.Z.-C., M.J.F., A.G.), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
| | - C A P F Alves
- From the Departments of Radiology and Division of Neuroradiology (F.G.G., B.H., C.A.P.F.A., S.R.T., J.S.M.-S., A.V., G.Z.)
| | - S R Teixeira
- From the Departments of Radiology and Division of Neuroradiology (F.G.G., B.H., C.A.P.F.A., S.R.T., J.S.M.-S., A.V., G.Z.)
| | - J S Martin-Saavedra
- From the Departments of Radiology and Division of Neuroradiology (F.G.G., B.H., C.A.P.F.A., S.R.T., J.S.M.-S., A.V., G.Z.)
| | - Z Zolkipli-Cunningham
- Mitochondrial Medicine Frontier Program, Division of Human Genetics (C.C.M., E.M., Z.Z.-C., M.J.F., A.G.), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.,Departments of Pediatrics (Y.G., Z.Z.-C., M.J.F., A.G.)
| | - M J Falk
- Mitochondrial Medicine Frontier Program, Division of Human Genetics (C.C.M., E.M., Z.Z.-C., M.J.F., A.G.), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.,Departments of Pediatrics (Y.G., Z.Z.-C., M.J.F., A.G.)
| | - A Vossough
- From the Departments of Radiology and Division of Neuroradiology (F.G.G., B.H., C.A.P.F.A., S.R.T., J.S.M.-S., A.V., G.Z.).,Radiology (A.V.), University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
| | - A Goldstein
- Mitochondrial Medicine Frontier Program, Division of Human Genetics (C.C.M., E.M., Z.Z.-C., M.J.F., A.G.), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.,Departments of Pediatrics (Y.G., Z.Z.-C., M.J.F., A.G.)
| | - G Zuccoli
- From the Departments of Radiology and Division of Neuroradiology (F.G.G., B.H., C.A.P.F.A., S.R.T., J.S.M.-S., A.V., G.Z.).,The Program for the Study of Neurodevelopment in Rare Disorders (NDRD) (G.Z.), Children's Hospital of Pittsburgh of UPMC
| |
Collapse
|
12
|
Fábrega-Foster K, Kamel IR, Horowitz JM, Arif-Tiwari H, Bashir MR, Chernyak V, Goldstein A, Grajo JR, Hindman NM, Kamaya A, McNamara MM, Porter KK, Scheiman JM, Solnes LB, Srivastava PK, Zaheer A, Carucci LR. ACR Appropriateness Criteria® Pancreatic Cyst. J Am Coll Radiol 2020; 17:S198-S206. [PMID: 32370963 DOI: 10.1016/j.jacr.2020.01.021] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2020] [Accepted: 01/25/2020] [Indexed: 02/07/2023]
Abstract
Incidental pancreatic cysts are increasingly detected on imaging studies performed for unrelated indications and may be incompletely characterized on these studies. Adequate morphological characterization is critical due to the small risk of malignant degeneration associated with neoplastic pancreatic cysts, as well as the risk of associated pancreatic adenocarcinoma. For all pancreatic cysts, both size and morphology determine management. Specifically, imaging detection of features, such as pancreatic ductal communication and presence or absence of worrisome features or high-risk stigmata, have important management implications. The recommendations in this publication determine the appropriate initial imaging study to further evaluate a pancreatic cyst that was incidentally detected on a nondedicated imaging study. The recommendations are designed to maximize the yield of diagnostic information in order to better risk-stratify pancreatic cysts and assist in guiding future management. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
Collapse
Affiliation(s)
| | - Ihab R Kamel
- Panel Chair, Johns Hopkins University School of Medicine, Baltimore, Maryland.
| | | | - Hina Arif-Tiwari
- University of Arizona, Banner University Medical Center, Tucson, Arizona
| | | | | | | | - Joseph R Grajo
- University of Florida College of Medicine, Gainesville, Florida
| | | | - Aya Kamaya
- Stanford University Medical Center, Stanford, California
| | | | | | - James M Scheiman
- University of Virginia Health System, Charlottesville, Virginia; American Gastroenterological Association
| | | | - Pavan K Srivastava
- University of Illinois College of Medicine, Chicago, Illinois; American College of Physicians
| | | | - Laura R Carucci
- Specialty Chair, Virginia Commonwealth University Medical Center, Richmond, Virginia
| |
Collapse
|
13
|
Bashir MR, Horowitz JM, Kamel IR, Arif-Tiwari H, Asrani SK, Chernyak V, Goldstein A, Grajo JR, Hindman NM, Kamaya A, McNamara MM, Porter KK, Solnes LB, Srivastava PK, Zaheer A, Carucci LR. ACR Appropriateness Criteria® Chronic Liver Disease. J Am Coll Radiol 2020; 17:S70-S80. [PMID: 32370979 DOI: 10.1016/j.jacr.2020.01.023] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2020] [Accepted: 01/25/2020] [Indexed: 12/12/2022]
Abstract
The liver fibrosis stage is the most important clinical determinate of morbidity and mortality in patients with chronic liver diseases. With newer therapies, liver fibrosis can be stabilized and possibly reversed, thus accurate diagnosis and staging of liver fibrosis are clinically important. Ultrasound, CT, and conventional MRI can be used to establish the diagnosis of advanced fibrosis/cirrhosis but have limited utility for assessing earlier stages of fibrosis. Elastography-based ultrasound and MRI techniques are more useful for assessment of precirrhotic hepatic fibrosis. In patients with advanced fibrosis at risk for hepatocellular carcinoma (HCC), ultrasound is the surveillance modality recommended by international guidelines in nearly all circumstances. However, in patients in whom ultrasound does not assess the liver well, including those with severe steatosis or obesity, multiphase CT or MRI may have a role in surveillance for HCC. Both multiphase CT and MRI can be used for continued surveillance in patients with a history of HCC, and contrast-enhanced ultrasound may have an emerging role in this setting. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
Collapse
Affiliation(s)
| | | | - Ihab R Kamel
- Panel Chair, Johns Hopkins University School of Medicine, Baltimore, Maryland
| | - Hina Arif-Tiwari
- University of Arizona, Banner University Medical Center, Tucson, Arizona
| | - Sumeet K Asrani
- Baylor University Medical Center, Dallas, Texas; American Association for the Study of Liver Diseases
| | | | | | - Joseph R Grajo
- University of Florida College of Medicine, Gainesville, Florida
| | | | - Aya Kamaya
- Stanford University Medical Center, Stanford, California
| | | | | | | | - Pavan K Srivastava
- University of Illinois College of Medicine, Chicago, Illinois; American College of Physicians
| | | | - Laura R Carucci
- Specialty Chair, Virginia Commonwealth University Medical Center, Richmond, Virginia
| |
Collapse
|
14
|
Murugan VA, Murphy BO, Dupuis C, Goldstein A, Kim YH. Role of ultrasound in the evaluation of first-trimester pregnancies in the acute setting. Ultrasonography 2020; 39:178-189. [PMID: 32036643 PMCID: PMC7065984 DOI: 10.14366/usg.19043] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2019] [Accepted: 10/16/2019] [Indexed: 11/16/2022] Open
Abstract
In patients presenting for an evaluation of pregnancy in the first trimester, transvaginal ultrasound is the modality of choice for establishing the presence of an intrauterine pregnancy; evaluating pregnancy viability, gestational age, and multiplicity; detecting pregnancy-related complications; and diagnosing ectopic pregnancy. In this pictorial review article, the sonographic appearance of a normal intrauterine gestation and the most common complications of pregnancy in the first trimester in the acute setting are discussed.
Collapse
Affiliation(s)
- Venkatesh A Murugan
- Department of Radiology, University of Massachusetts Medical School, Worcester, MA, USA
| | | | - Carolyn Dupuis
- Department of Radiology, University of Massachusetts Medical School, Worcester, MA, USA
| | - Alan Goldstein
- Department of Radiology, University of Massachusetts Medical School, Worcester, MA, USA
| | - Young H Kim
- Department of Radiology, University of Massachusetts Medical School, Worcester, MA, USA
| |
Collapse
|
15
|
Wu CZ, Goldstein A, Klebanoff J, Moawad GN. 2196 Vulvar Vestibulectomy with Vaginal Advancement Flap for Neuroproliferative Vulvodynia. J Minim Invasive Gynecol 2019. [DOI: 10.1016/j.jmig.2019.09.302] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
16
|
Porter KK, Zaheer A, Kamel IR, Horowitz JM, Arif-Tiwari H, Bartel TB, Bashir MR, Camacho MA, Cash BD, Chernyak V, Goldstein A, Grajo JR, Gupta S, Hindman NM, Kamaya A, McNamara MM, Carucci LR. ACR Appropriateness Criteria® Acute Pancreatitis. J Am Coll Radiol 2019; 16:S316-S330. [DOI: 10.1016/j.jacr.2019.05.017] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2019] [Accepted: 05/14/2019] [Indexed: 12/19/2022]
|
17
|
Dor-Ziderman Y, Lutz A, Goldstein A. Prediction-based neural mechanisms for shielding the self from existential threat. Neuroimage 2019; 202:116080. [PMID: 31401240 DOI: 10.1016/j.neuroimage.2019.116080] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2019] [Revised: 07/25/2019] [Accepted: 08/06/2019] [Indexed: 12/28/2022] Open
Abstract
The human mind has an automatic tendency to avoid awareness of its mortality. How this protective mechanism is implemented at the neuronal level is unknown. Here we test the hypothesis that prediction-based mechanisms mediate death-denial by shielding the self from existential threat. We provide evidence that self-specific predictive processes are downregulated during the perception of death-related linguistic stimuli and that this mechanism can predict fear-of-death. Using a magnetoencephalography visual mismatch paradigm, we show that the brain's automatic prediction response to deviancy is eliminated when death words and self-face representations are coupled, but remains present when coupled to other-face or to negative words. We further demonstrate a functional link between how death impacts self-image vs. Other-image, and show that it predicts fear-of-death. Finally, we confirm this effect in a behavioral active inference experiment showing that death-related words bias perceptual judgment on facial self and other morphed video clips. Together these results lay out, for the first time, a plausible neural-based mechanism of death-denial.
Collapse
Affiliation(s)
- Y Dor-Ziderman
- Gonda Brain Research Center, Bar Ilan University, Ramat-Gan, Israel.
| | - A Lutz
- Lyon Neuroscience Research Center, INSERM, U1028, CNRS UMR5292, Lyon 1 University, Lyon, 69500, France
| | - A Goldstein
- Gonda Brain Research Center, Bar Ilan University, Ramat-Gan, Israel; Department of Psychology, Bar Ilan University, Ramat-Gan, Israel
| |
Collapse
|
18
|
Conforto I, Samir C, Chausse F, Goldstein A, Pereira B, Coudeyre E. Comparison of psychometric properties between the Labin, a new electronic dynamometer, and the Jamar: Preliminary results in healthy subjects. Hand Surg Rehabil 2019; 38:293-297. [PMID: 31386926 DOI: 10.1016/j.hansur.2019.07.009] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/10/2019] [Revised: 07/25/2019] [Accepted: 07/26/2019] [Indexed: 11/30/2022]
Abstract
Many instruments exist for measuring grip strength. The Jamar hydraulic hand dynamometer is currently the gold standard. The Labin is a prototype electronic dynamometer that can also measure maximum grip strength. The main objective was to compare the Labin dynamometer with the gold standard instrument, the Jamar, in a healthy population, and secondarily to compare discomfort during use. A single-center exploratory study was conducted. The subjects enrolled had to be aged between 20 and 60, be volunteers and give consent. The required number of subjects was 30. The subjects were positioned according to American Society of Hand Therapists recommendations. Maximum grip force was measured in kilograms using the mean of three successive trials. The first dynamometer used was chosen randomly. The handle's discomfort during use was rated on a simple verbal scale from 0 to 10. Thirty-four subjects were included. The concordance coefficient for peak torque between the Labin and Jamar dynamometers was 0.90 for the dominant hand and 0.83 for the non-dominant hand. The intraclass correlation coefficient for peak torque with the Labin was 0.81 [0.69; 0.89] for the dominant hand and 0.86 [0.76; 0.92] for the non-dominant hand. In our study, we have shown that the Labin prototype has acceptable validity and reproducibility. The Labin will need to be tested in pathological conditions next.
Collapse
Affiliation(s)
- I Conforto
- Service de médecine physique et réadaptation, CHU de Clermont-Ferrand, INRA, université Clermont-Auvergne, Route de Chateaugay, 63118 Cébazat, France
| | - C Samir
- Laboratoire LIMOS, université Clermont-Auvergne, 63178 Aubière cedex, France; Université Clermont Auvergne, CNRS, SIGMA Clermont, institut Pascal, 63000 Clermont-Ferrand, France
| | - F Chausse
- Laboratoire LIMOS, université Clermont-Auvergne, 63178 Aubière cedex, France; Université Clermont Auvergne, CNRS, SIGMA Clermont, institut Pascal, 63000 Clermont-Ferrand, France
| | - A Goldstein
- Service de médecine physique et réadaptation, CHU de Clermont-Ferrand, INRA, université Clermont-Auvergne, Route de Chateaugay, 63118 Cébazat, France
| | - B Pereira
- University hospital Clermont-Ferrand, biostatistics unit (DRCI), 63003 Clermont-Ferrand, France
| | - E Coudeyre
- Service de médecine physique et réadaptation, CHU de Clermont-Ferrand, INRA, université Clermont-Auvergne, Route de Chateaugay, 63118 Cébazat, France.
| |
Collapse
|
19
|
Goldstein A, Catus F, Picaut P. 100 Rationale and Design for a Phase II Trial of Abobotulinumtoxina (Dysport) in the Management of Vulvodynia. J Sex Med 2019. [DOI: 10.1016/j.jsxm.2019.03.538] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
20
|
Govind V, Mitchell L, Tolson H, Barela K, Casey J, Goldstein A. 085 Exploring Comorbidity of Anxiety and Depression in Vulvodynia with Associated Overactive Pelvic Floor Muscle Dysfunction. J Sex Med 2019. [DOI: 10.1016/j.jsxm.2019.03.526] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
21
|
Govind V, Mitchell L, Tolson H, Barela K, Casey J, Goldstein A. 089 Exploring Comorbidity of Anxiety and Depression in Lichen Sclerosus. J Sex Med 2019. [DOI: 10.1016/j.jsxm.2019.03.530] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
22
|
Nissim M, Hutzler Y, Goldstein A. A walk on water: comparing the influence of Ai Chi and Tai Chi on fall risk and verbal working memory in ageing people with intellectual disabilities - a randomised controlled trial. J Intellect Disabil Res 2019; 63:603-613. [PMID: 30775818 DOI: 10.1111/jir.12602] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/10/2018] [Revised: 12/18/2018] [Accepted: 01/14/2019] [Indexed: 06/09/2023]
Abstract
BACKGROUND Aquatic motor intervention has been found to be effective in reducing falls and improving verbal working memory among the general population. However, effects among older adults with intellectual disabilities (ID) have never been explored. The aim of this study was to examine the effects of aquatic motor intervention on fall risk and verbal working memory among older adults with ID. METHODS Forty-one older adults with mild to moderate ID (age: 50-66 years) were randomly assigned to 14 weeks of aquatic motor intervention (Ai Chi: N = 19) or identical on-land motor intervention (Tai Chi: N = 22). Fall risk, measured with the Tinetti balance assessment tool (TBAT), and verbal working memory, measured with the digit span forward test, were assessed pre-intervention, after 7 weeks of intervention and post-intervention. RESULTS Study results indicate positive effects of both aquatic and on-land motor intervention on TBAT fall risk score, while the aquatic motor intervention group improved TBAT fall risk score quicker as compared with the on-land motor intervention group. Moreover, the lower the pre-intervention TBAT score was, the higher the improvement. In addition, study findings support the positive effects of aquatic motor intervention on verbal working memory ability as measured with the digit span forward test. CONCLUSIONS Motor intervention, and particularly in an aquatic environment, can potentially reduce fall risk. Aquatic motor intervention may help to improve verbal working memory among older adults with ID.
Collapse
Affiliation(s)
- M Nissim
- The Gonda Multidisciplinary Brain Research Center, Bar-Ilan University, Ramat-Gan, Israel
| | - Y Hutzler
- The Academic College at Wingate, Netanya, Israel
| | - A Goldstein
- The Gonda Multidisciplinary Brain Research Center, Bar-Ilan University, Ramat-Gan, Israel
| |
Collapse
|
23
|
Goldstein A, Mitchell L, Govind V, Heller D. 007 A Randomized Double-Blind Placebo Controlled Trial of Autologous Platelet Rich Plasma Intradermal Injections for the Treatment of Vulvar Lichen Sclerosus. J Sex Med 2019. [DOI: 10.1016/j.jsxm.2019.03.464] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
24
|
Goldstein A, Quintana Diez P, Kapanadze S, Cala M, Evans C, Whyte J, Christoph A. 119 The Vulvodynia Experience Questionnaire (VEQ): Qualitative Development of a New Patient-Reported Outcome Measure for Vulvodynia. J Sex Med 2019. [DOI: 10.1016/j.jsxm.2019.03.557] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
25
|
Cigna S, Mitchell L, Goldstein A. 025 Lysis of Vulvar Adhesions for Lichen Sclerosus: A Series of 5 Patients. J Sex Med 2018. [DOI: 10.1016/j.jsxm.2018.03.036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
26
|
Cigna S, Mitchell L, Goldstein A. 079 Vulvar Crohn’s: A Rare Presentation of Crohn’s Disease. J Sex Med 2018. [DOI: 10.1016/j.jsxm.2018.03.070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
27
|
Fitch K, Cho E, Goldstein A, Weinstock M, Qureshi A, Li W. 308 Host characteristics and risk of atypical nevi. J Invest Dermatol 2018. [DOI: 10.1016/j.jid.2018.03.314] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
28
|
Rubin R, Mitchell L, Winter A, Goldstein A, Goldstein I. 011 Successful Treatment of Interstitial Cystitis/Bladder Pain Syndrome (IC/PBS) in Women with Provoked Vestibulodynia (PVD). J Sex Med 2018. [DOI: 10.1016/j.jsxm.2017.11.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
29
|
Albers DJ, Elhadad N, Claassen J, Perotte R, Goldstein A, Hripcsak G. Estimating summary statistics for electronic health record laboratory data for use in high-throughput phenotyping algorithms. J Biomed Inform 2018; 78:87-101. [PMID: 29369797 PMCID: PMC5856130 DOI: 10.1016/j.jbi.2018.01.004] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2017] [Revised: 12/05/2017] [Accepted: 01/14/2018] [Indexed: 01/12/2023]
Abstract
We study the question of how to represent or summarize raw laboratory data taken from an electronic health record (EHR) using parametric model selection to reduce or cope with biases induced through clinical care. It has been previously demonstrated that the health care process (Hripcsak and Albers, 2012, 2013), as defined by measurement context (Hripcsak and Albers, 2013; Albers et al., 2012) and measurement patterns (Albers and Hripcsak, 2010, 2012), can influence how EHR data are distributed statistically (Kohane and Weber, 2013; Pivovarov et al., 2014). We construct an algorithm, PopKLD, which is based on information criterion model selection (Burnham and Anderson, 2002; Claeskens and Hjort, 2008), is intended to reduce and cope with health care process biases and to produce an intuitively understandable continuous summary. The PopKLD algorithm can be automated and is designed to be applicable in high-throughput settings; for example, the output of the PopKLD algorithm can be used as input for phenotyping algorithms. Moreover, we develop the PopKLD-CAT algorithm that transforms the continuous PopKLD summary into a categorical summary useful for applications that require categorical data such as topic modeling. We evaluate our methodology in two ways. First, we apply the method to laboratory data collected in two different health care contexts, primary versus intensive care. We show that the PopKLD preserves known physiologic features in the data that are lost when summarizing the data using more common laboratory data summaries such as mean and standard deviation. Second, for three disease-laboratory measurement pairs, we perform a phenotyping task: we use the PopKLD and PopKLD-CAT algorithms to define high and low values of the laboratory variable that are used for defining a disease state. We then compare the relationship between the PopKLD-CAT summary disease predictions and the same predictions using empirically estimated mean and standard deviation to a gold standard generated by clinical review of patient records. We find that the PopKLD laboratory data summary is substantially better at predicting disease state. The PopKLD or PopKLD-CAT algorithms are not meant to be used as phenotyping algorithms, but we use the phenotyping task to show what information can be gained when using a more informative laboratory data summary. In the process of evaluation our method we show that the different clinical contexts and laboratory measurements necessitate different statistical summaries. Similarly, leveraging the principle of maximum entropy we argue that while some laboratory data only have sufficient information to estimate a mean and standard deviation, other laboratory data captured in an EHR contain substantially more information than can be captured in higher-parameter models.
Collapse
Affiliation(s)
- D J Albers
- Department of Biomedical Informatics, Columbia University, 622 West 168th Street, New York, NY, USA.
| | - N Elhadad
- Department of Biomedical Informatics, Columbia University, 622 West 168th Street, New York, NY, USA.
| | - J Claassen
- Department of Neurology, Columbia University, 710 West 168th Street, New York, NY 10032, USA.
| | - R Perotte
- Value Institute, New York Presbyterian Hospital, 601 West 168th Street New York, NY 10032, USA.
| | - A Goldstein
- Department of Biomedical Informatics, Columbia University, 622 West 168th Street, New York, NY, USA.
| | - G Hripcsak
- Department of Biomedical Informatics, Columbia University, 622 West 168th Street, New York, NY, USA.
| |
Collapse
|
30
|
Vernon H, Cohen J, De Nittis P, Fatemi A, McClellan R, Goldstein A, Malerba N, Guex N, Reymond A, Merla G. Intellectual developmental disorder with cardiac arrhythmia syndrome in a child with compound heterozygous GNB5 variants. Clin Genet 2018; 93:1254-1256. [PMID: 29368331 DOI: 10.1111/cge.13194] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2017] [Revised: 11/30/2017] [Accepted: 12/04/2017] [Indexed: 11/30/2022]
Abstract
Identification of a novel compound heterozygous of GNB5 in a patient with intellectual developmental disorder with cardiac arrhytmia (IDDCA), from non-consaguineous family. Three-dimensional modelling and in silico predictions suggest that GNB5 variants are causative of the phenotype, extending the number of IDDCA patients so far identified.
Collapse
Affiliation(s)
- H Vernon
- Department of Neurogenetics, Kennedy Krieger Institute, Baltimore, Maryland
| | - J Cohen
- Department of Neurogenetics, Kennedy Krieger Institute, Baltimore, Maryland
| | - P De Nittis
- Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland
| | - A Fatemi
- Department of Neurogenetics, Kennedy Krieger Institute, Baltimore, Maryland
| | - R McClellan
- Department of Neurogenetics, Kennedy Krieger Institute, Baltimore, Maryland
| | - A Goldstein
- Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
| | - N Malerba
- Division of Medical Genetics, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Foggia, Italy
| | - N Guex
- Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.,Swiss Institute of Bioinformatics, Lausanne, Switzerland
| | - A Reymond
- Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland
| | - G Merla
- Division of Medical Genetics, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Foggia, Italy
| |
Collapse
|
31
|
King M, Mitchell L, Belkin Z, Goldstein A. 036 Vulvar Vestibulectomy for Neuroproliferative Associated Vestibulodynia: A Retrospective Case-Control Study. J Sex Med 2017. [DOI: 10.1016/j.jsxm.2017.04.040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
32
|
Goldstein L, Goldstein A, Kellogg-Spadt S, Marfori C, Goldstein A. 002 Digital Cervicography for Quality Control of Visualization With Acetic Acid (VIA) for Cervical Dysplasia Screening. J Sex Med 2017. [DOI: 10.1016/j.jsxm.2017.04.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
33
|
Bissaldi E, Connaughton V, Omodei N, Burns E, Goldstein A, Vianello G. The Fermi GBM and LAT follow-up of GW150914. EPJ Web Conf 2017. [DOI: 10.1051/epjconf/201713603020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
34
|
Weizman N, Baidun K, Goldstein A, Amit U, Lawrence Y, Appel S, Benayun M, Dubinski S, Orion I, Alezra D, Gnessin H, Symon Z, Goldstein J. Effects of Continuous Positive Airway Pressure (CPAP) Used for Respiratory Motion Management in Patients Receiving Chest Radiation to the Heart: An Analysis of Size, Position, and Motion. Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2016.06.2277] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
35
|
Goldstein A. Well-Functioning Offices. J Am Dent Assoc 2016; 147:696. [DOI: 10.1016/j.adaj.2016.07.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
36
|
|
37
|
Samim M, Goldstein A, Schindler J, Johnson MH. Multimodality Imaging of Vertebrobasilar Dolichoectasia: Clinical Presentations and Imaging Spectrum. Radiographics 2016; 36:1129-46. [PMID: 27315445 DOI: 10.1148/rg.2016150032] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Vertebrobasilar dolichoectasia (VBD) is characterized by ectasia, elongation, and tortuosity of the vertebrobasilar arteries, with a high degree of variability in clinical presentation. The disease origin is believed to involve degeneration of the internal elastic lamina, thinning of the media secondary to reticular fiber deficiency, and smooth muscle atrophy. The prevalence of VBD is variable, ranging from 0.05% to 18%. Most patients with VBD are asymptomatic and their VBD is detected incidentally; however, it is important to recognize that the presence of symptoms, which can lead to clinically significant morbidity and sometimes mortality, may influence clinical management. The most important clinical presentations of VBD are vascular events, such as ischemic stroke and catastrophic intracranial hemorrhage, or progressive compressive symptoms related to compression of adjacent structures, including the cranial nerves, brainstem, or third ventricle, causing hydrocephalus. The imaging diagnostic criteria for computed tomography and magnetic resonance (MR) imaging include three quantitative measures of basilar artery morphology: laterality score, height of bifurcation, and basilar artery diameter. The authors review the relevant anatomy and disease origin of VBD; pertinent imaging findings, including intraluminal thrombus and relation to the cranial nerves; and imaging pitfalls, such as the hyperintense vessel sign on MR images and artifacts related to slow flow in the dolichoectatic vessel. In addition, clinical manifestations, the role of radiology in diagnosis and management of this condition, and available management options are reviewed. (©)RSNA, 2016.
Collapse
Affiliation(s)
- Mohammad Samim
- From the Departments of Diagnostic Radiology (M.S., A.G., M.H.J.) and Neurology (J.S.), Yale University School of Medicine, 20 York St, New Haven, CT 06510
| | - Alan Goldstein
- From the Departments of Diagnostic Radiology (M.S., A.G., M.H.J.) and Neurology (J.S.), Yale University School of Medicine, 20 York St, New Haven, CT 06510
| | - Joseph Schindler
- From the Departments of Diagnostic Radiology (M.S., A.G., M.H.J.) and Neurology (J.S.), Yale University School of Medicine, 20 York St, New Haven, CT 06510
| | - Michele H Johnson
- From the Departments of Diagnostic Radiology (M.S., A.G., M.H.J.) and Neurology (J.S.), Yale University School of Medicine, 20 York St, New Haven, CT 06510
| |
Collapse
|
38
|
Perez-Losada M, Goldstein A, Alamri L, Crandall KA, Freishtat RJ. 20: NASOPHARYNX MICROBIOME COMPOSITION VARIES OVER TIME IN PEDIATRIC ASTHMA. J Investig Med 2016. [DOI: 10.1136/jim-2016-000080.36] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Purpose of StudyThe application of next-generation sequencing (NGS) technology has shown that microbial communities in the respiratory airways (i.e., the microbiome) play a significant role in the onset, development and severity of asthma. However, little is known about their temporal dynamics (i.e., microbial succession), which poses a significant obstacle to identifying pulmotypes of disease and assessing inter-patient variation. Here, we couple NGS and 16S rRNA data to characterize the nasopharynx microbiome of children with asthma and determine its stability over time.Methods UsedWe collected nasal washes from 40 children with asthma enrolled in the AsthMaP-2 Project from two consecutive visits, six months apart. Total DNA was extracted and sequenced for the 16S-V4 rRNA gene region (∼250 bp) using the MySeq Illumina platform. Reads were analyzed in Mothur using the SILVAv119 reference database. Alpha diversity metrics and phylogenetic and count-base distance community indexes of beta diversity were compared across samples and time points. PCoA and NJ clustering analysis were used to assess community relatedness. Differences in alpha diversity and OTU abundance between sample pairs across time points were also compared.Summary of ResultsA mean of 27,479 clean 16S sequences corresponding to an average of 173 OTUs were sequenced and detected per sample, respectively. Representatives of Moraxella, Corynebacterium, Prevotella, Staphylococcus, Alloiococcus, Streptococcus, Peptoniphilus, Fusobacterium, and Haemophilus accounted for 36 to 99% of the reads across samples. These genera have been previously found in the nasopharynx of asthmatic and healthy children. A total of 61 OTUs from these genera were present in at least 50% of the samples (i.e., the nasal core microbiome). Significant differences in core microbiome composition were detected between sample pairs, but no directional trend (increase or decrease) was observed across sample pairs. Samples were randomly ordinated and did not cluster together.ConclusionsOur analysis of nasal microbiomes in 40 asthmatic children revealed significant differences in composition within individuals over six months. Future cross-sectional microbiome studies need to be aware of short span temporal dynamics in nasal microbiota.
Collapse
|
39
|
Connaughton V, Briggs MS, Goldstein A, Meegan CA, Paciesas WS, Preece RD, Wilson-Hodge CA, Gibby MH, Greiner J, Gruber D, Jenke P, Kippen RM, Pelassa V, Xiong S, Yu HF, Bhat PN, Burgess JM, Byrne D, Fitzpatrick G, Foley S, Giles MM, Guiriec S, van der Horst AJ, von Kienlin A, McBreen S, McGlynn S, Tierney D, Zhang BB. LOCALIZATION OF GAMMA-RAY BURSTS USING THE
FERMI
GAMMA-RAY BURST MONITOR. ACTA ACUST UNITED AC 2015. [DOI: 10.1088/0067-0049/216/2/32] [Citation(s) in RCA: 69] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
40
|
Ackermann M, Ajello M, Asano K, Atwood WB, Axelsson M, Baldini L, Ballet J, Barbiellini G, Baring MG, Bastieri D, Bechtol K, Bellazzini R, Bissaldi E, Bonamente E, Bregeon J, Brigida M, Bruel P, Buehler R, Burgess JM, Buson S, Caliandro GA, Cameron RA, Caraveo PA, Cecchi C, Chaplin V, Charles E, Chekhtman A, Cheung CC, Chiang J, Chiaro G, Ciprini S, Claus R, Cleveland W, Cohen-Tanugi J, Collazzi A, Cominsky LR, Connaughton V, Conrad J, Cutini S, D’Ammando F, de Angelis A, DeKlotz M, de Palma F, Dermer CD, Desiante R, Diekmann A, Di Venere L, Drell PS, Drlica-Wagner A, Favuzzi C, Fegan SJ, Ferrara EC, Finke J, Fitzpatrick G, Focke WB, Franckowiak A, Fukazawa Y, Funk S, Fusco P, Gargano F, Gehrels N, Germani S, Gibby M, Giglietto N, Giles M, Giordano F, Giroletti M, Godfrey G, Granot J, Grenier IA, Grove JE, Gruber D, Guiriec S, Hadasch D, Hanabata Y, Harding AK, Hayashida M, Hays E, Horan D, Hughes RE, Inoue Y, Jogler T, Jóhannesson G, Johnson WN, Kawano T, Knödlseder J, Kocevski D, Kuss M, Lande J, Larsson S, Latronico L, Longo F, Loparco F, Lovellette MN, Lubrano P, Mayer M, Mazziotta MN, McEnery JE, Michelson PF, Mizuno T, Moiseev AA, Monzani ME, Moretti E, Morselli A, Moskalenko IV, Murgia S, Nemmen R, Nuss E, Ohno M, Ohsugi T, Okumura A, Omodei N, Orienti M, Paneque D, Pelassa V, Perkins JS, Pesce-Rollins M, Petrosian V, Piron F, Pivato G, Porter TA, Racusin JL, Rainò S, Rando R, Razzano M, Razzaque S, Reimer A, Reimer O, Ritz S, Roth M, Ryde F, Sartori A, Parkinson PMS, Scargle JD, Schulz A, Sgrò C, Siskind EJ, Sonbas E, Spandre G, Spinelli P, Tajima H, Takahashi H, Thayer JG, Thayer JB, Thompson DJ, Tibaldo L, Tinivella M, Torres DF, Tosti G, Troja E, Usher TL, Vandenbroucke J, Vasileiou V, Vianello G, Vitale V, Winer BL, Wood KS, Yamazaki R, Younes G, Yu HF, Zhu SJ, Bhat PN, Briggs MS, Byrne D, Foley S, Goldstein A, Jenke P, Kippen RM, Kouveliotou C, McBreen S, Meegan C, Paciesas WS, Preece R, Rau A, Tierney D, van der Horst AJ, von Kienlin A, Wilson-Hodge C, Xiong S, Cusumano G, La Parola V, Cummings JR. Fermi-LAT Observations of the Gamma-Ray Burst GRB 130427A. Science 2014; 343:42-7. [DOI: 10.1126/science.1242353] [Citation(s) in RCA: 176] [Impact Index Per Article: 17.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
Affiliation(s)
- M. Ackermann
- Deutsches Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany
| | - M. Ajello
- Space Sciences Laboratory, University of California, Berkeley, CA 94720, USA
| | - K. Asano
- Institute for Cosmic Ray Research, University of Tokyo, 5-1-5 Kashiwa-no-Ha, Kashiwa City, Chiba 277-8582, Japan
| | - W. B. Atwood
- Santa Cruz Institute for Particle Physics, Department of Physics, and Department of Astronomy and Astrophysics, University of California, Santa Cruz, CA 95064, USA
| | - M. Axelsson
- Department of Astronomy, Stockholm University, SE-106 91 Stockholm, Sweden
- Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
- Department of Physics, Royal Institute of Technology (KTH), AlbaNova, SE-106 91 Stockholm, Sweden
| | - L. Baldini
- Università di Pisa and Istituto Nazionale di Fisica Nucleare, Sezione di Pisa I-56127 Pisa, Italy
| | - J. Ballet
- Laboratoire AIM, CEA-IRFU/CNRS/Université Paris Diderot, Service d’Astrophysique, CEA Saclay, 91191 Gif sur Yvette, France
| | - G. Barbiellini
- Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, I-34127 Trieste, Italy
- Dipartimento di Fisica, Università di Trieste, I-34127 Trieste, Italy
| | - M. G. Baring
- Department of Physics and Astronomy, Rice University, Houston, TX 77251, USA
| | - D. Bastieri
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- Dipartimento di Fisica e Astronomia “G. Galilei,” Università di Padova, I-35131 Padova, Italy
| | - K. Bechtol
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - R. Bellazzini
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - E. Bissaldi
- Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, and Università di Trieste, I-34127 Trieste, Italy
| | - E. Bonamente
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
- Dipartimento di Fisica, Università degli Studi di Perugia, I-06123 Perugia, Italy
| | - J. Bregeon
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - M. Brigida
- Dipartimento di Fisica “M. Merlin” dell’Università e del Politecnico di Bari, I-70126 Bari, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, 70126 Bari, Italy
| | - P. Bruel
- Laboratoire Leprince-Ringuet, École Polytechnique, CNRS/IN2P3, Palaiseau, France
| | - R. Buehler
- Deutsches Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany
| | - J. Michael Burgess
- Center for Space Plasma and Aeronomic Research, University of Alabama, Huntsville, AL 35899, USA
| | - S. Buson
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- Dipartimento di Fisica e Astronomia “G. Galilei,” Università di Padova, I-35131 Padova, Italy
| | - G. A. Caliandro
- Institut de Ciències de l’Espai (IEEE-CSIC), Campus UAB, 08193 Barcelona, Spain
| | - R. A. Cameron
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - P. A. Caraveo
- INAF–Istituto di Astrofisica Spaziale e Fisica Cosmica, I-20133 Milano, Italy
| | - C. Cecchi
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
- Dipartimento di Fisica, Università degli Studi di Perugia, I-06123 Perugia, Italy
| | - V. Chaplin
- Center for Space Plasma and Aeronomic Research, University of Alabama, Huntsville, AL 35899, USA
| | - E. Charles
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - A. Chekhtman
- Center for Earth Observing and Space Research, College of Science, George Mason University, Fairfax, VA 22030, USA; resident at Naval Research Laboratory, Washington, DC 20375, USA
| | - C. C. Cheung
- Space Science Division, Naval Research Laboratory, Washington, DC 20375, USA
| | - J. Chiang
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - G. Chiaro
- Dipartimento di Fisica e Astronomia “G. Galilei,” Università di Padova, I-35131 Padova, Italy
| | - S. Ciprini
- Agenzia Spaziale Italiana Science Data Center, I-00044 Frascati (Roma), Italy
- Istituto Nazionale di Astrofisica–Osservatorio Astronomico di Roma, I-00040 Monte Porzio Catone (Roma), Italy
| | - R. Claus
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - W. Cleveland
- Universities Space Research Association, Columbia, MD 21044, USA
| | - J. Cohen-Tanugi
- Laboratoire Univers et Particules de Montpellier, Université Montpellier 2, CNRS/IN2P3, Montpellier, France
| | | | - L. R. Cominsky
- Department of Physics and Astronomy, Sonoma State University, Rohnert Park, CA 94928, USA
| | - V. Connaughton
- Center for Space Plasma and Aeronomic Research, University of Alabama, Huntsville, AL 35899, USA
| | - J. Conrad
- Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
- Department of Physics, Stockholm University, AlbaNova, SE-106 91 Stockholm, Sweden
- Royal Swedish Academy of Sciences Research Fellow, funded by a grant from the K. A. Wallenberg Foundation
- Royal Swedish Academy of Sciences, Box 50005, SE-104 05 Stockholm, Sweden
| | - S. Cutini
- Agenzia Spaziale Italiana Science Data Center, I-00044 Frascati (Roma), Italy
- Istituto Nazionale di Astrofisica–Osservatorio Astronomico di Roma, I-00040 Monte Porzio Catone (Roma), Italy
| | - F. D’Ammando
- INAF Istituto di Radioastronomia, 40129 Bologna, Italy
| | - A. de Angelis
- Dipartimento di Fisica, Università di Udine, and Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, Gruppo Collegato di Udine, I-33100 Udine, Italy
| | - M. DeKlotz
- Stellar Solutions Inc., 250 Cambridge Avenue, Suite 204, Palo Alto, CA 94306, USA
| | - F. de Palma
- Dipartimento di Fisica “M. Merlin” dell’Università e del Politecnico di Bari, I-70126 Bari, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, 70126 Bari, Italy
| | - C. D. Dermer
- Space Science Division, Naval Research Laboratory, Washington, DC 20375, USA
| | - R. Desiante
- Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, I-34127 Trieste, Italy
| | - A. Diekmann
- Jacobs Technology, Huntsville, AL 35806, USA
| | - L. Di Venere
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - P. S. Drell
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - A. Drlica-Wagner
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - C. Favuzzi
- Dipartimento di Fisica “M. Merlin” dell’Università e del Politecnico di Bari, I-70126 Bari, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, 70126 Bari, Italy
| | - S. J. Fegan
- Laboratoire Leprince-Ringuet, École Polytechnique, CNRS/IN2P3, Palaiseau, France
| | - E. C. Ferrara
- NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA
| | - J. Finke
- Space Science Division, Naval Research Laboratory, Washington, DC 20375, USA
| | | | - W. B. Focke
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - A. Franckowiak
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - Y. Fukazawa
- Department of Physical Sciences, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - S. Funk
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - P. Fusco
- Dipartimento di Fisica “M. Merlin” dell’Università e del Politecnico di Bari, I-70126 Bari, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, 70126 Bari, Italy
| | - F. Gargano
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, 70126 Bari, Italy
| | - N. Gehrels
- NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA
| | - S. Germani
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
- Dipartimento di Fisica, Università degli Studi di Perugia, I-06123 Perugia, Italy
| | - M. Gibby
- Jacobs Technology, Huntsville, AL 35806, USA
| | - N. Giglietto
- Dipartimento di Fisica “M. Merlin” dell’Università e del Politecnico di Bari, I-70126 Bari, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, 70126 Bari, Italy
| | - M. Giles
- Jacobs Technology, Huntsville, AL 35806, USA
| | - F. Giordano
- Dipartimento di Fisica “M. Merlin” dell’Università e del Politecnico di Bari, I-70126 Bari, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, 70126 Bari, Italy
| | - M. Giroletti
- INAF Istituto di Radioastronomia, 40129 Bologna, Italy
| | - G. Godfrey
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - J. Granot
- Department of Natural Sciences, Open University of Israel, Ra’anana 43537, Israel
| | - I. A. Grenier
- Laboratoire AIM, CEA-IRFU/CNRS/Université Paris Diderot, Service d’Astrophysique, CEA Saclay, 91191 Gif sur Yvette, France
| | - J. E. Grove
- Space Science Division, Naval Research Laboratory, Washington, DC 20375, USA
| | - D. Gruber
- Max-Planck-Institut für Extraterrestrische Physik, 85748 Garching, Germany
| | - S. Guiriec
- NASA Postdoctoral Program Fellow, USA
- NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA
| | - D. Hadasch
- Institut de Ciències de l’Espai (IEEE-CSIC), Campus UAB, 08193 Barcelona, Spain
| | - Y. Hanabata
- Department of Physical Sciences, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - A. K. Harding
- NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA
| | - M. Hayashida
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
- Department of Astronomy, Graduate School of Science, Kyoto University, Sakyo-ku, Kyoto 606-8502, Japan
| | - E. Hays
- NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA
| | - D. Horan
- Laboratoire Leprince-Ringuet, École Polytechnique, CNRS/IN2P3, Palaiseau, France
| | - R. E. Hughes
- Department of Physics, Center for Cosmology and Astro-Particle Physics, Ohio State University, Columbus, OH 43210, USA
| | - Y. Inoue
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - T. Jogler
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - G. Jóhannesson
- Science Institute, University of Iceland, IS-107 Reykjavik, Iceland
| | - W. N. Johnson
- Space Science Division, Naval Research Laboratory, Washington, DC 20375, USA
| | - T. Kawano
- Department of Physical Sciences, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - J. Knödlseder
- CNRS, IRAP, F-31028 Toulouse Cedex 4, France
- GAHEC, Université de Toulouse, UPS-OMP, IRAP, Toulouse, France
| | - D. Kocevski
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - M. Kuss
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - J. Lande
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - S. Larsson
- Department of Astronomy, Stockholm University, SE-106 91 Stockholm, Sweden
- Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
- Department of Physics, Stockholm University, AlbaNova, SE-106 91 Stockholm, Sweden
| | - L. Latronico
- Istituto Nazionale di Fisica Nucleare, Sezione di Torino, I-10125 Torino, Italy
| | - F. Longo
- Istituto Nazionale di Fisica Nucleare, Sezione di Trieste, I-34127 Trieste, Italy
- Dipartimento di Fisica, Università di Trieste, I-34127 Trieste, Italy
| | - F. Loparco
- Dipartimento di Fisica “M. Merlin” dell’Università e del Politecnico di Bari, I-70126 Bari, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, 70126 Bari, Italy
| | - M. N. Lovellette
- Space Science Division, Naval Research Laboratory, Washington, DC 20375, USA
| | - P. Lubrano
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
- Dipartimento di Fisica, Università degli Studi di Perugia, I-06123 Perugia, Italy
| | - M. Mayer
- Deutsches Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany
| | - M. N. Mazziotta
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, 70126 Bari, Italy
| | - J. E. McEnery
- NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA
- Department of Physics and Department of Astronomy, University of Maryland, College Park, MD 20742, USA
| | - P. F. Michelson
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - T. Mizuno
- Hiroshima Astrophysical Science Center, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - A. A. Moiseev
- Department of Physics and Department of Astronomy, University of Maryland, College Park, MD 20742, USA
- Center for Research and Exploration in Space Science and Technology (CRESST) and NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA
| | - M. E. Monzani
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - E. Moretti
- Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
- Department of Physics, Royal Institute of Technology (KTH), AlbaNova, SE-106 91 Stockholm, Sweden
| | - A. Morselli
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma “Tor Vergata,” I-00133 Roma, Italy
| | - I. V. Moskalenko
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - S. Murgia
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - R. Nemmen
- NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA
| | - E. Nuss
- Laboratoire Univers et Particules de Montpellier, Université Montpellier 2, CNRS/IN2P3, Montpellier, France
| | - M. Ohno
- Department of Physical Sciences, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - T. Ohsugi
- Hiroshima Astrophysical Science Center, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - A. Okumura
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
- Solar-Terrestrial Environment Laboratory, Nagoya University, Nagoya 464-8601, Japan
| | - N. Omodei
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - M. Orienti
- INAF Istituto di Radioastronomia, 40129 Bologna, Italy
| | - D. Paneque
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
- Max-Planck-Institut für Physik, D-80805 München, Germany
| | - V. Pelassa
- Center for Space Plasma and Aeronomic Research, University of Alabama, Huntsville, AL 35899, USA
| | - J. S. Perkins
- NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA
- Center for Research and Exploration in Space Science and Technology (CRESST) and NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA
- Department of Physics and Center for Space Sciences and Technology, University of Maryland Baltimore County, Baltimore, MD 21250, USA
| | - M. Pesce-Rollins
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - V. Petrosian
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - F. Piron
- Laboratoire Univers et Particules de Montpellier, Université Montpellier 2, CNRS/IN2P3, Montpellier, France
| | - G. Pivato
- Dipartimento di Fisica e Astronomia “G. Galilei,” Università di Padova, I-35131 Padova, Italy
| | - T. A. Porter
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - J. L. Racusin
- NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA
| | - S. Rainò
- Dipartimento di Fisica “M. Merlin” dell’Università e del Politecnico di Bari, I-70126 Bari, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, 70126 Bari, Italy
| | - R. Rando
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, I-35131 Padova, Italy
- Dipartimento di Fisica e Astronomia “G. Galilei,” Università di Padova, I-35131 Padova, Italy
| | - M. Razzano
- Santa Cruz Institute for Particle Physics, Department of Physics, and Department of Astronomy and Astrophysics, University of California, Santa Cruz, CA 95064, USA
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - S. Razzaque
- Department of Physics, University of Johannesburg, Auckland Park 2006, South Africa
| | - A. Reimer
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
- Institut für Astro- und Teilchenphysik and Institut für Theoretische Physik, Leopold-Franzens-Universität Innsbruck, A-6020 Innsbruck, Austria
| | - O. Reimer
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
- Institut für Astro- und Teilchenphysik and Institut für Theoretische Physik, Leopold-Franzens-Universität Innsbruck, A-6020 Innsbruck, Austria
| | - S. Ritz
- Santa Cruz Institute for Particle Physics, Department of Physics, and Department of Astronomy and Astrophysics, University of California, Santa Cruz, CA 95064, USA
| | - M. Roth
- Department of Physics, University of Washington, Seattle, WA 98195, USA
| | - F. Ryde
- Oskar Klein Centre for Cosmoparticle Physics, AlbaNova, SE-106 91 Stockholm, Sweden
- Department of Physics, Royal Institute of Technology (KTH), AlbaNova, SE-106 91 Stockholm, Sweden
| | - A. Sartori
- INAF–Istituto di Astrofisica Spaziale e Fisica Cosmica, I-20133 Milano, Italy
| | - P. M. Saz Parkinson
- Santa Cruz Institute for Particle Physics, Department of Physics, and Department of Astronomy and Astrophysics, University of California, Santa Cruz, CA 95064, USA
| | - J. D. Scargle
- Space Sciences Division, NASA Ames Research Center, Moffett Field, CA 94035, USA
| | - A. Schulz
- Deutsches Elektronen Synchrotron DESY, D-15738 Zeuthen, Germany
| | - C. Sgrò
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - E. J. Siskind
- NYCB Real-Time Computing Inc., Lattingtown, NY 11560, USA
| | - E. Sonbas
- Universities Space Research Association, Columbia, MD 21044, USA
- NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA
- Adyaman University, 02040 Adyaman, Turkey
| | - G. Spandre
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - P. Spinelli
- Dipartimento di Fisica “M. Merlin” dell’Università e del Politecnico di Bari, I-70126 Bari, Italy
- Istituto Nazionale di Fisica Nucleare, Sezione di Bari, 70126 Bari, Italy
| | - H. Tajima
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
- Solar-Terrestrial Environment Laboratory, Nagoya University, Nagoya 464-8601, Japan
| | - H. Takahashi
- Department of Physical Sciences, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8526, Japan
| | - J. G. Thayer
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - J. B. Thayer
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - D. J. Thompson
- NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA
| | - L. Tibaldo
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - M. Tinivella
- Istituto Nazionale di Fisica Nucleare, Sezione di Pisa, I-56127 Pisa, Italy
| | - D. F. Torres
- Institut de Ciències de l’Espai (IEEE-CSIC), Campus UAB, 08193 Barcelona, Spain
- Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
| | - G. Tosti
- Istituto Nazionale di Fisica Nucleare, Sezione di Perugia, I-06123 Perugia, Italy
- Dipartimento di Fisica, Università degli Studi di Perugia, I-06123 Perugia, Italy
| | - E. Troja
- NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA
- Department of Physics and Department of Astronomy, University of Maryland, College Park, MD 20742, USA
| | - T. L. Usher
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - J. Vandenbroucke
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
| | - V. Vasileiou
- Laboratoire Univers et Particules de Montpellier, Université Montpellier 2, CNRS/IN2P3, Montpellier, France
| | - G. Vianello
- W. W. Hansen Experimental Physics Laboratory, Kavli Institute for Particle Astrophysics and Cosmology, Department of Physics and SLAC National Accelerator Laboratory, Stanford University, Stanford, CA 94305, USA
- Consorzio Interuniversitario per la Fisica Spaziale (CIFS), I-10133 Torino, Italy
| | - V. Vitale
- Istituto Nazionale di Fisica Nucleare, Sezione di Roma “Tor Vergata,” I-00133 Roma, Italy
- Dipartimento di Fisica, Università di Roma “Tor Vergata,” I-00133 Roma, Italy
| | - B. L. Winer
- Department of Physics, Center for Cosmology and Astro-Particle Physics, Ohio State University, Columbus, OH 43210, USA
| | - K. S. Wood
- Space Science Division, Naval Research Laboratory, Washington, DC 20375, USA
| | - R. Yamazaki
- Department of Physics and Mathematics, Aoyama Gakuin University, Sagamihara, Kanagawa 252-5258, Japan
| | - G. Younes
- Universities Space Research Association, Columbia, MD 21044, USA
- NASA Marshall Space Flight Center, Huntsville, AL 35812, USA
| | - H.-F. Yu
- Max-Planck-Institut für Extraterrestrische Physik, 85748 Garching, Germany
| | - S. J. Zhu
- Department of Physics and Department of Astronomy, University of Maryland, College Park, MD 20742, USA
| | - P. N. Bhat
- Center for Space Plasma and Aeronomic Research, University of Alabama, Huntsville, AL 35899, USA
| | - M. S. Briggs
- Center for Space Plasma and Aeronomic Research, University of Alabama, Huntsville, AL 35899, USA
| | - D. Byrne
- University College Dublin, Belfield, Dublin 4, Ireland
| | - S. Foley
- University College Dublin, Belfield, Dublin 4, Ireland
- Max-Planck-Institut für Extraterrestrische Physik, 85748 Garching, Germany
| | - A. Goldstein
- Center for Space Plasma and Aeronomic Research, University of Alabama, Huntsville, AL 35899, USA
| | - P. Jenke
- Center for Space Plasma and Aeronomic Research, University of Alabama, Huntsville, AL 35899, USA
| | - R. M. Kippen
- Los Alamos National Laboratory, Los Alamos, NM 87545, USA
| | - C. Kouveliotou
- NASA Marshall Space Flight Center, Huntsville, AL 35812, USA
| | - S. McBreen
- University College Dublin, Belfield, Dublin 4, Ireland
- Max-Planck-Institut für Extraterrestrische Physik, 85748 Garching, Germany
| | - C. Meegan
- Center for Space Plasma and Aeronomic Research, University of Alabama, Huntsville, AL 35899, USA
| | - W. S. Paciesas
- Universities Space Research Association, Columbia, MD 21044, USA
| | - R. Preece
- Center for Space Plasma and Aeronomic Research, University of Alabama, Huntsville, AL 35899, USA
| | - A. Rau
- Max-Planck-Institut für Extraterrestrische Physik, 85748 Garching, Germany
| | - D. Tierney
- University College Dublin, Belfield, Dublin 4, Ireland
| | - A. J. van der Horst
- Astronomical Institute Änton Pannekoek, University of Amsterdam, 1090 GE Amsterdam, Netherlands
| | - A. von Kienlin
- Max-Planck-Institut für Extraterrestrische Physik, 85748 Garching, Germany
| | - C. Wilson-Hodge
- NASA Marshall Space Flight Center, Huntsville, AL 35812, USA
| | - S. Xiong
- Center for Space Plasma and Aeronomic Research, University of Alabama, Huntsville, AL 35899, USA
| | - G. Cusumano
- INAF–Istituto di Astrofisica Spaziale e Fisica Cosmica, Via U. La Malfa 153, I-90146 Palermo, Italy
| | - V. La Parola
- INAF–Istituto di Astrofisica Spaziale e Fisica Cosmica, Via U. La Malfa 153, I-90146 Palermo, Italy
| | - J. R. Cummings
- NASA Goddard Space Flight Center, Greenbelt, MD 20771, USA
- Center for Research and Exploration in Space Science & Technology, University of Maryland, Baltimore County, Baltimore, MD 21250, USA
| |
Collapse
|
41
|
Preece R, Burgess JM, von Kienlin A, Bhat PN, Briggs MS, Byrne D, Chaplin V, Cleveland W, Collazzi AC, Connaughton V, Diekmann A, Fitzpatrick G, Foley S, Gibby M, Giles M, Goldstein A, Greiner J, Gruber D, Jenke P, Kippen RM, Kouveliotou C, McBreen S, Meegan C, Paciesas WS, Pelassa V, Tierney D, van der Horst AJ, Wilson-Hodge C, Xiong S, Younes G, Yu HF, Ackermann M, Ajello M, Axelsson M, Baldini L, Barbiellini G, Baring MG, Bastieri D, Bellazzini R, Bissaldi E, Bonamente E, Bregeon J, Brigida M, Bruel P, Buehler R, Buson S, Caliandro GA, Cameron RA, Caraveo PA, Cecchi C, Charles E, Chekhtman A, Chiang J, Chiaro G, Ciprini S, Claus R, Cohen-Tanugi J, Cominsky LR, Conrad J, D'Ammando F, de Angelis A, de Palma F, Dermer CD, Desiante R, Digel SW, Di Venere L, Drell PS, Drlica-Wagner A, Favuzzi C, Franckowiak A, Fukazawa Y, Fusco P, Gargano F, Gehrels N, Germani S, Giglietto N, Giordano F, Giroletti M, Godfrey G, Granot J, Grenier IA, Guiriec S, Hadasch D, Hanabata Y, Harding AK, Hayashida M, Iyyani S, Jogler T, Jóhannesson G, Kawano T, Knödlseder J, Kocevski D, Kuss M, Lande J, Larsson J, Larsson S, Latronico L, Longo F, Loparco F, Lovellette MN, Lubrano P, Mayer M, Mazziotta MN, Michelson PF, Mizuno T, Monzani ME, Moretti E, Morselli A, Murgia S, Nemmen R, Nuss E, Nymark T, Ohno M, Ohsugi T, Okumura A, Omodei N, Orienti M, Paneque D, Perkins JS, Pesce-Rollins M, Piron F, Pivato G, Porter TA, Racusin JL, Rainò S, Rando R, Razzano M, Razzaque S, Reimer A, Reimer O, Ritz S, Roth M, Ryde F, Sartori A, Scargle JD, Schulz A, Sgrò C, Siskind EJ, Spandre G, Spinelli P, Suson DJ, Tajima H, Takahashi H, Thayer JG, Thayer JB, Tibaldo L, Tinivella M, Torres DF, Tosti G, Troja E, Usher TL, Vandenbroucke J, Vasileiou V, Vianello G, Vitale V, Werner M, Winer BL, Wood KS, Zhu S. The First Pulse of the Extremely Bright GRB 130427A: A Test Lab for Synchrotron Shocks. Science 2014; 343:51-4. [DOI: 10.1126/science.1242302] [Citation(s) in RCA: 49] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
Affiliation(s)
- R Preece
- Department of Space Science, University of Alabama in Huntsville, Huntsville, AL 35899, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
42
|
Goldstein A. Are you "into" your patients? Dent Today 2013; 32:8-10. [PMID: 24151724] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
|
43
|
Goldstein A. Happiness for people who can't stand positive thinking. Dent Today 2013; 32:12-13. [PMID: 23431864] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
|
44
|
|
45
|
Dotan Ben Soussan T, Glicksohn J, Ohana AB, Donchin O, Goldstein A. P8.15 Gender dependent manifestation of functional connectivity following Quadrato Motor Training. Clin Neurophysiol 2011. [DOI: 10.1016/s1388-2457(11)60346-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
46
|
Penot A, Abraham J, Debarri H, Desport E, Aguilar C, Lavergne D, Auroy F, Leleu X, Goldstein A, Kolb B, Bridoux F, Fermand JP, Leblond V, Jaccard A. Effectiveness of second-line treatment in AL amyloidosis patient's refractory to M-Dex. Amyloid 2011; 18 Suppl 1:145-7. [PMID: 21838466 DOI: 10.3109/13506129.2011.574354054] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Affiliation(s)
- A Penot
- Service d'Hématologie, CHU, Limoges, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Goldstein A. The leader as servant. Dent Today 2010; 29:10-12. [PMID: 20873644] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
|
48
|
Straus OH, Goldstein A. ZONE BEHAVIOR OF ENZYMES : ILLUSTRATED BY THE EFFECT OF DISSOCIATION CONSTANT AND DILUTION ON THE SYSTEM CHOLINESTERASE-PHYSOSTIGMINE. ACTA ACUST UNITED AC 2010; 26:559-85. [PMID: 19873367 PMCID: PMC2142573 DOI: 10.1085/jgp.26.6.559] [Citation(s) in RCA: 205] [Impact Index Per Article: 14.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
1. The kinetics of the reversible combination of one enzyme center with one molecule of a substrate or inhibitor is treated as a true bimolecular instead of a pseudomonomolecular reaction. The general equations describing such a reaction are presented and analyzed algebraically and graphically. 2. A new term, "specific concentration," is introduced to denote the concentration of reactants in units equal to the dissociation constant. Its use makes the kinetic equations universally applicable to all reversible systems of the given type. 3. It is shown that such a system exhibits three "zones" of behavior. Each zone is characterized and shown to exhibit significant differences in the function relating the concentrations of the components of the system at equilibrium. The zone boundaries are rigorously defined in terms of the specific enzyme concentration, for the mathematical error tolerable with a given experimental accuracy; and approximate boundaries for practical use are proposed. 4. The classical treatment of enzyme kinetics is shown to be a limiting case valid only for low specific enzyme concentrations (zone A) and to be inapplicable in a number of systems whose dissociation constants are very small or whose molar enzyme concentrations are very great, and in which, therefore, the specific enzyme concentrations are large. See Table I for a summary of zone differences. 5. In an enzyme system containing substrate or inhibitor, dilution before determination of reaction velocities is shown to be a crucial operation, entailing large changes in the fraction of enzyme in the form of a complex. The changes in fractional activity or inhibition with dilution are shown to be a function of specific enzyme concentration, the dilution factor, and the fraction of enzyme initially in the form of complex. Equations are given permitting the calculation of the state of the system at any concentration. The errors introduced into physiological work by failure to take the dilution effect into account are pointed out. 6. Experimental data are presented showing that the system composed of serum cholinesterase and physostigmine behaves as predicted by the dilution effect equations. 7. Two other conclusions of practical pharmacological importance are drawn from the theory of zone behavior: (a) The finding that a biological response is a linear function of the dose of a drug does not necessarily mean that the reaction is irreversible, but only that if reversible, the reactant with which the drug combines has a high specific concentration. (b) If a tissue enzyme has a high specific concentration, all reversible inhibitors will be equally potent in combining with it, regardless of their relative potency in dilute systems; provided only that their dissociation constants are within certain broad limits. 8. It is shown how the type of analysis here applied to bimolecular reactions can be applied in toto to systems of the type E + nX ⇋ EXn, where n molecules of substrate or inhibitor unite with one enzyme center. The zone boundaries and the magnitude of the dilution effect change with n, but the general characteristics of the zones are the same for all values of n. 9. Since the analysis is based only on mass law assumptions, it is applicable to any system that is formally analogous to the one here treated.
Collapse
Affiliation(s)
- O H Straus
- Department of Pharmacology, The Harvard Medical School, Boston
| | | | | |
Collapse
|
49
|
Abstract
The mechanism of enzyme-inhibitor-substrate reactions has been analyzed from a theoretical standpoint and illustrated by data from the system cholinesterase-physostigmine-acetylcholine. This treatment is by no means limited to a single system but should be generally applicable to others of similar type. Competitive enzyme-inhibitor-substrate systems show the same characteristic "zones of behavior" already demonstrated for non-competitive systems by Straus and Goldstein. These zones, three in number, determine the mathematical function which relates activity of an enzyme to concentration of an added substrate or inhibitor or both. The effects of suboptimal substrate concentration in such systems have been considered, and the errors arising from various common simplifications of the descriptive equations have been pointed out. The zone behavior phenomenon has been shown to be useful in determining the number of molecules of substrate or inhibitor combining reversibly with a single enzyme center. The kinetics of competitive inhibition, dilution effect, combination of inhibitor or substrate with enzyme, and destruction of inhibitor or substrate by enzyme have been analyzed and experimentally verified, and absolute velocity constants have been determined. Theoretical conclusions have been discussed from the standpoint of their physiological significance. Specifically, it has been shown that: 1. The inhibition of cholinesterase by physostigmine is competitive. A single molecule of physostigmine or acetylcholine combines with one center of cholinesterase—n = 1; and the mechanism n = 2 has been. excluded. Numerical values of the constants for this system are as follows: KI = 3.11 x 10–8k1 (combination) = 8.3 x 105k2 (dissociation) = 0.026 KS = 1.25 x 10–3k3 (combination) = 260 k4 (dissociation) = 0.32 2. No definitive value can be assigned to E, the molar concentration of enzyme centers, but in 4.54 per cent dog serum, E < 1.8 x 10–8 (EI' < 0.58). The system therefore operates in (or nearly in) zone A at this concentration. 3. Competitive displacement of inhibitor by substrate and vice versa introduces considerable error in the usual 20 minute determination of the activity of an inhibited enzyme, unless properly corrected for. 4. Dissociation of the enzyme-inhibitor complex on dilution proceeds moderately slowly so that the full corrections for dilution cannot be applied unless time has been allowed for full dissociation. 5. Combination of physostigmine with cholinesterase is slow at all but large concentrations of inhibitor. 6. The destruction of physostigmine or acetylcholine by cholinesterase follows the predicted curve; kD for the destruction of physostigmine is found to be > 0.00182; kD for acetylcholine destruction is > 3500. There is no reason to assume inhibition of destruction by excess substrate or inhibitor. 7. The common assumption that enzymatic activity follows (or nearly follows) a monomolecular course is true only under limited conditions, which have been here defined. It is not valid, as a rule, for the enzymatic destruction of an inhibitor (e.g., physostigmine) and its application to such a case may lead to erroneous conclusions about the reaction mechanism.
Collapse
Affiliation(s)
- A Goldstein
- Department of Pharmacology, The Harvard Medical School, Boston
| |
Collapse
|
50
|
Travaglini L, Brancati F, Attie-Bitach T, Audollent S, Bertini E, Kaplan J, Perrault I, Iannicelli M, Mancuso B, Rigoli L, Rozet JM, Swistun D, Tolentino J, Dallapiccola B, Gleeson JG, Valente EM, Zankl A, Leventer R, Grattan-Smith P, Janecke A, D'Hooghe M, Sznajer Y, Van Coster R, Demerleir L, Dias K, Moco C, Moreira A, Kim CA, Maegawa G, Petkovic D, Abdel-Salam GMH, Abdel-Aleem A, Zaki MS, Marti I, Quijano-Roy S, Sigaudy S, de Lonlay P, Romano S, Touraine R, Koenig M, Lagier-Tourenne C, Messer J, Collignon P, Wolf N, Philippi H, Kitsiou Tzeli S, Halldorsson S, Johannsdottir J, Ludvigsson P, Phadke SR, Udani V, Stuart B, Magee A, Lev D, Michelson M, Ben-Zeev B, Fischetto R, Benedicenti F, Stanzial F, Borgatti R, Accorsi P, Battaglia S, Fazzi E, Giordano L, Pinelli L, Boccone L, Bigoni S, Ferlini A, Donati MA, Caridi G, Divizia MT, Faravelli F, Ghiggeri G, Pessagno A, Briguglio M, Briuglia S, Salpietro CD, Tortorella G, Adami A, Castorina P, Lalatta F, Marra G, Riva D, Scelsa B, Spaccini L, Uziel G, Del Giudice E, Laverda AM, Ludwig K, Permunian A, Suppiej A, Signorini S, Uggetti C, Battini R, Di Giacomo M, Cilio MR, Di Sabato ML, Leuzzi V, Parisi P, Pollazzon M, Silengo M, De Vescovi R, Greco D, Romano C, Cazzagon M, Simonati A, Al-Tawari AA, Bastaki L, Mégarbané A, Sabolic Avramovska V, de Jong MM, Stromme P, Koul R, Rajab A, Azam M, Barbot C, Martorell Sampol L, Rodriguez B, Pascual-Castroviejo I, Teber S, Anlar B, Comu S, Karaca E, Kayserili H, Yüksel A, Akcakus M, Al Gazali L, Sztriha L, Nicholl D, Woods CG, Bennett C, Hurst J, Sheridan E, Barnicoat A, Hennekam R, Lees M, Blair E, Bernes S, Sanchez H, Clark AE, DeMarco E, Donahue C, Sherr E, Hahn J, Sanger TD, Gallager TE, Dobyns WB, Daugherty C, Krishnamoorthy KS, Sarco D, Walsh CA, McKanna T, Milisa J, Chung WK, De Vivo DC, Raynes H, Schubert R, Seward A, Brooks DG, Goldstein A, Caldwell J, Finsecke E, Maria BL, Holden K, Cruse RP, Swoboda KJ, Viskochil D. Expanding CEP290 mutational spectrum in ciliopathies. Am J Med Genet A 2009; 149A:2173-80. [PMID: 19764032 DOI: 10.1002/ajmg.a.33025] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
Ciliopathies are an expanding group of rare conditions characterized by multiorgan involvement, that are caused by mutations in genes encoding for proteins of the primary cilium or its apparatus. Among these genes, CEP290 bears an intriguing allelic spectrum, being commonly mutated in Joubert syndrome and related disorders (JSRD), Meckel syndrome (MKS), Senior-Loken syndrome and isolated Leber congenital amaurosis (LCA). Although these conditions are recessively inherited, in a subset of patients only one CEP290 mutation could be detected. To assess whether genomic rearrangements involving the CEP290 gene could represent a possible mutational mechanism in these cases, exon dosage analysis on genomic DNA was performed in two groups of CEP290 heterozygous patients, including five JSRD/MKS cases and four LCA, respectively. In one JSRD patient, we identified a large heterozygous deletion encompassing CEP290 C-terminus that resulted in marked reduction of mRNA expression. No copy number alterations were identified in the remaining probands. The present work expands the CEP290 genotypic spectrum to include multiexon deletions. Although this mechanism does not appear to be frequent, screening for genomic rearrangements should be considered in patients in whom a single CEP290 mutated allele was identified.
Collapse
Affiliation(s)
- Lorena Travaglini
- CSS-Mendel Institute, Casa Sollievo della Sofferenza Hospital, Rome, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|